{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:44:00Z","timestamp":1773938640374,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["ShenzhenE010122001"],"award-info":[{"award-number":["ShenzhenE010122001"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.pan.2025.12.015","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T07:15:35Z","timestamp":1765782935000},"page":"164-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Elevated circulating glycine levels are associated with reduced pancreatic cancer risk: A prospective cohort study based on the UK biobank"],"prefix":"10.1016","volume":"26","author":[{"given":"Shuai","family":"Xiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunlong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxu","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Che","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongxing","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pan.2025.12.015_bib1","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"Mizrahi","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.pan.2025.12.015_bib2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","article-title":"Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019","volume":"8","author":"Kocarnik","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.pan.2025.12.015_bib3","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S2468-1253(19)30347-4","article-title":"The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"4","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.pan.2025.12.015_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41392-024-02098-3","article-title":"Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status","volume":"10","author":"Hu","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.pan.2025.12.015_bib5","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.pan.2025.12.015_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/science.1242454","article-title":"Fueling immunity: insights into metabolism and lymphocyte function","volume":"342","author":"Pearce","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.pan.2025.12.015_bib7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer hallmark even warburg did not anticipate","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pan.2025.12.015_bib8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12943-020-01169-7","article-title":"Metabolism of pancreatic cancer: paving the way to better anticancer strategies","volume":"19","author":"Qin","year":"2020","journal-title":"Mol Cancer"},{"key":"10.1016\/j.pan.2025.12.015_bib9","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cac2.12360","article-title":"Lipid metabolism in pancreatic cancer: emerging roles and potential targets","volume":"42","author":"Yin","year":"2022","journal-title":"Cancer Commun"},{"key":"10.1016\/j.pan.2025.12.015_bib10","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2008.08.026","article-title":"Metabolic phenotyping in health and disease","volume":"134","author":"Holmes","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.pan.2025.12.015_bib11","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/4551054a","article-title":"Systems biology: metabonomics","volume":"455","author":"Nicholson","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.pan.2025.12.015_bib12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12032-016-0853-6","article-title":"Metabolomics in pancreatic cancer biomarkers research","volume":"33","author":"Tumas","year":"2016","journal-title":"Med Oncol"},{"key":"10.1016\/j.pan.2025.12.015_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13070872","article-title":"Evaluating metabolite-based biomarkers for early diagnosis of pancreatic cancer: a systematic review","volume":"13","author":"Perazzoli","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.pan.2025.12.015_bib14","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/ijc.34208","article-title":"Metabolomic analyses redefine the biological classification of pancreatic cancer and correlate with clinical outcomes","volume":"151","author":"Guo","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pan.2025.12.015_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18040767","article-title":"Serum metabolomic profiles for human pancreatic cancer discrimination","volume":"18","author":"Itoi","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pan.2025.12.015_bib16","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/ng.429","article-title":"Genome-wide association study identifies variants in the abo locus associated with susceptibility to pancreatic cancer","volume":"41","author":"Amundadottir","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.pan.2025.12.015_bib17","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/ng.522","article-title":"A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33","volume":"42","author":"Petersen","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.pan.2025.12.015_bib18","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/ng.3052","article-title":"Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer","volume":"46","author":"Wolpin","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.pan.2025.12.015_bib19","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1053\/j.gastro.2022.01.016","article-title":"Predicting pancreatic cancer in the UK biobank cohort using polygenic risk scores and diabetes mellitus","volume":"162","author":"Sharma","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pan.2025.12.015_bib20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.pan.2025.12.015_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"Uk biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.pan.2025.12.015_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12916-022-02354-9","article-title":"Predictive value of circulating nmr metabolic biomarkers for type 2 diabetes risk in the UK biobank study","volume":"20","author":"Bragg","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.pan.2025.12.015_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203386","article-title":"Prediction model for pancreatic cancer risk in the general japanese population","volume":"13","author":"Nakatochi","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.pan.2025.12.015_bib24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1136\/jmedgenet-2020-106961","article-title":"Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction","volume":"58","author":"Galeotti","year":"2021","journal-title":"J Med Genet"},{"key":"10.1016\/j.pan.2025.12.015_bib25","first-page":"319","article-title":"Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity\/bmi through causal inference and mediation analyses","volume":"70","author":"Molina-Montes","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.pan.2025.12.015_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkaa021","article-title":"Evaluating the utility of polygenic risk scores in identifying high-risk individuals for eight common cancers","volume":"4","author":"Jia","year":"2020","journal-title":"JNCI Cancer Spectr"},{"key":"10.1016\/j.pan.2025.12.015_bib27","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1038\/s41467-020-18246-6","article-title":"Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts","volume":"11","author":"Rashkin","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.pan.2025.12.015_bib28","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/s12916-023-03202-0","article-title":"Association of genetic risk and lifestyle with pancreatic cancer and their age dependency: a large prospective cohort study in the UK biobank","volume":"21","author":"Zeng","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.pan.2025.12.015_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14092199","article-title":"The association between serum serine and glycine and related-metabolites with pancreatic cancer in a prospective cohort study","volume":"14","author":"Luu","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.pan.2025.12.015_bib30","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1158\/1940-6207.CAPR-18-0201","article-title":"A prospective targeted serum metabolomics study of pancreatic cancer in postmenopausal women","volume":"12","author":"Jiao","year":"2019","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.pan.2025.12.015_bib31","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ygyno.2021.06.001","article-title":"Prospective analysis of circulating metabolites and endometrial cancer risk","volume":"162","author":"Dossus","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.pan.2025.12.015_bib32","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/sj.bjc.6605764","article-title":"Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis","volume":"103","author":"Xue","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pan.2025.12.015_bib33","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1038\/bjc.2012.458","article-title":"Serum apolipoprotein c-ii is prognostic for survival after pancreatic resection for adenocarcinoma","volume":"107","author":"Xue","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pan.2025.12.015_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/1389557516666160609081602","article-title":"Beneficial effects of the amino acid glycine","volume":"17","author":"P\u00e9rez-Torres","year":"2017","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.pan.2025.12.015_bib35","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00726-013-1493-1","article-title":"Glycine metabolism in animals and humans: implications for nutrition and health","volume":"45","author":"Wang","year":"2013","journal-title":"Amino Acids"},{"key":"10.1016\/j.pan.2025.12.015_bib36","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1210\/jc.2013-2376","article-title":"Effect of increasing glutathione with cysteine and glycine supplementation on mitochondrial fuel oxidation, insulin sensitivity, and body composition in older hiv-infected patients","volume":"99","author":"Nguyen","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pan.2025.12.015_bib37","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1002\/jnr.22395","article-title":"The inhibitory neurotransmitter glycine modulates macrophage activity by activation of neutral amino acid transporters","volume":"88","author":"Carmans","year":"2010","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pan.2025.12.015_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.762564","article-title":"Glycinergic signaling in macrophages and its application in macrophage-associated diseases","volume":"12","author":"Gan","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.pan.2025.12.015_bib39","doi-asserted-by":"crossref","first-page":"G1105","DOI":"10.1152\/ajpgi.00465.2015","article-title":"Glycine prevents metabolic steatohepatitis in diabetic kk-ay mice through modulation of hepatic innate immunity","volume":"311","author":"Takashima","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.pan.2025.12.015_bib40","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1126\/science.1218595","article-title":"Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation","volume":"336","author":"Jain","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.pan.2025.12.015_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9121770","article-title":"Reduction of rapid proliferating tumour cell lines by inhibition of the specific glycine transporter glyt1","volume":"9","author":"Bierhals","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.pan.2025.12.015_bib42","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nature22056","article-title":"Modulating the therapeutic response of tumours to dietary serine and glycine starvation","volume":"544","author":"Maddocks","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.pan.2025.12.015_bib43","doi-asserted-by":"crossref","first-page":"772","DOI":"10.7150\/ijbs.104458","article-title":"Glycine decarboxylase regulates renal carcinoma progression via interferon stimulated gene factor 3-mediated pathway","volume":"21","author":"Pham","year":"2025","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.pan.2025.12.015_bib44","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cell.2011.11.050","article-title":"Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis","volume":"148","author":"Zhang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.pan.2025.12.015_bib45","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.omtn.2017.10.001","article-title":"Induced-decay of glycine decarboxylase transcripts as an anticancer therapeutic strategy for non-small-cell lung carcinoma","volume":"9","author":"Lin","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.pan.2025.12.015_bib46","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/ng.890","article-title":"Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis","volume":"43","author":"Locasale","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.pan.2025.12.015_bib47","article-title":"Differential expression of enzymes associated with serine\/glycine metabolism in different breast cancer subtypes","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pan.2025.12.015_bib48","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/1759-7714.13064","article-title":"Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non-small cell lung cancer patients","volume":"10","author":"Liao","year":"2019","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.pan.2025.12.015_bib49","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1755-148X.2011.00919.x","article-title":"Phgdh amplification and altered glucose metabolism in human melanoma","volume":"24","author":"Mullarky","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.pan.2025.12.015_bib50","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10350","article-title":"Functional genomics reveal that the serine synthesis pathway is essential in breast cancer","volume":"476","author":"Possemato","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pan.2025.12.015_bib51","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1073\/pnas.1521548113","article-title":"Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers","volume":"113","author":"Mullarky","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pan.2025.12.015_bib52","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nchembio.2070","article-title":"A phgdh inhibitor reveals coordination of serine synthesis and one-carbon unit fate","volume":"12","author":"Pacold","year":"2016","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.pan.2025.12.015_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/nu11061356","article-title":"Glycine metabolism and its alterations in obesity and metabolic diseases","volume":"11","author":"Alves","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.pan.2025.12.015_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz2841","article-title":"Glycine-based treatment ameliorates nafld by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome","volume":"12","author":"Rom","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.pan.2025.12.015_bib55","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1093\/annonc\/mds491","article-title":"Cigarette smoking and pancreatic cancer: an analysis from the international pancreatic cancer case-control consortium (panc4)","volume":"23","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.pan.2025.12.015_bib56","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJM196807252790401","article-title":"Daily rhythms in the concentrations of various amino acids in human plasma","volume":"279","author":"Wurtman","year":"1968","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pan.2025.12.015_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/nu15112638","article-title":"Characterisation of fasting and postprandial nmr metabolites: insights from the zoe predict 1 study","volume":"15","author":"Bermingham","year":"2023","journal-title":"Nutrients"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390325007239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390325007239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:18:30Z","timestamp":1773933510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390325007239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1424390325007239"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2025.12.015","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated circulating glycine levels are associated with reduced pancreatic cancer risk: A prospective cohort study based on the UK biobank","name":"articletitle","label":"Article Title"},{"value":"Pancreatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pan.2025.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 IAP and EPC. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}